Interpretation of health-related quality of life outcomes in Parkinson's disease from the EARLYSTIM Study.

The EARLYSTIM Study compared deep brain stimulation (DBS) with best medical treatment (BMT) over 2-years, showing a between-group difference of 8.0 from baseline in favor of DBS in health-related quality of life (HRQoL), measured with the PDQ-39 SI (summary index). This study obtained complementary...

Full description

Bibliographic Details
Main Authors: Pablo Martinez-Martin, Guenther Deuschl, Lisa Tonder, Alfons Schnitzler, Jean-Luc Houeto, Lars Timmermann, Joern Rau, Carmen Schade-Brittinger, Valerie Stoker, Marie Vidailhet, Paul Krack, EARLYSTIM Study Group
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0237498